Fierce Healthcare

AUGUST 23, 2024

The healthcare industry confronts a complex, double-barreled challenge as it tries to combat the recent deluge of dangerous and damaging cyberattacks. | Cyber resilience is the ability to recognize threats, respond to them, recover quickly and at scale. The clear goal: fending off attacks more efficiently, limiting damage and restoring normal operations with minimal impact to patients.

138

138

Pharmacy Times

AUGUST 23, 2024

The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.

FDA 149

FDA 149

STAT

AUGUST 29, 2024

On Thursday, the California Department of Food and Agriculture announced it is investigating the possible introduction of H5N1 bird flu in cattle at three dairy farms in the Central Valley. If confirmed, they would be the first known cases in that state. In a statement, officials said testing of samples from the three farms is currently underway in the state’s veterinary diagnostic lab.

145

145

Fierce Pharma

AUGUST 20, 2024

Regulators in both the U.S. and Europe have looked into the potential link between suicidal thoughts and Novo Nordisk’s blockbuster semaglutide franchise after reports sounded the alarm last year. | Researchers found that users of Novo's semaglutide who were logged in a WHO database were more likely to report suicidal ideation.

140

140

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

AUGUST 6, 2024

Discover how the innovative geko device is driving clinical change in UK stroke care. Learn how this technology is revolutionising the treatment and management of stroke patients.

131

131

PharmaVoice

AUGUST 28, 2024

By rejecting the first MDMA therapy earlier this month, the FDA signaled to the psychedelic drug sector that the road to approval isn’t clear cut.

FDA 134

FDA 134

Pharmacy Times

AUGUST 29, 2024

Pharmacists can provide extra resources for patients, including explanations of the therapy options for the patients, the course of therapy, and what patients can expect.

149

149

STAT

AUGUST 28, 2024

MIDDLETOWN, Conn. — UnitedHealth Group told the Connecticut primary care doctors everything they wanted to hear. Take our money, the company said, and together we can bring about a future where primary care leads. A future where doctors can take better care of their patients, and reap the financial rewards of improved health. We’ll handle the business side while you look after your patients.

145

145

Fierce Pharma

AUGUST 23, 2024

Bayer’s latest round of layoffs has reportedly hit Basel, Switzerland, home of the international headquarters of the company's consumer health division. | The layoffs are the latest in Bayer's massive restructuring plan that has so far impacted more than 3,000 staffers since the start of the year.

142

142

pharmaphorum

AUGUST 21, 2024

Demonstrating EVERSANA's dedication to innovation, a novel artificial intelligence technology is set to enhance the NAVLIN experience for both current and prospective customers.

122

122

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

BioPharm

AUGUST 21, 2024

Under a deal worth potentially up to $1.3 billion, Merck, known as MSD outside of the United States and Canada, will acquire CN201, a next-generation bispecific antibody, from Curon Biopharmaceutical.

122

122

Fierce Healthcare

AUGUST 14, 2024

Entrepreneur and investor Mark Cuban wants to "f--k up" the U.S. healthcare system to make it more affordable, the billionaire told "The Daily Show" host Jon Stewart this week. | Entrepreneur and investor Mark Cuban wants to "f--k up" the U.S. healthcare system to make it more affordable, the billionaire told "The Daily Show" host Jon Stewart this week.

141

141

Pharmacy Times

AUGUST 5, 2024

Small adjustments in human pluripotent stem cell cultures and the molecule concentration patterns in the initial 5 days of differentiation are essential to “rescue” the lines.

156

156

STAT

AUGUST 27, 2024

Nearly two dozen people in the United States have been confirmed to have contracted the Oropouche virus during travels outside the country this summer, the Centers for Disease Control and Prevention reported Tuesday. A previously little-known virus, Oropouche has garnered headlines in recent weeks with reports of a small number of deaths and a possible link to congenital malformations in babies infected in the womb.

145

145

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

AUGUST 5, 2024

While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market. | While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market.

Vaccines 145

Vaccines 145

Outsourcing Pharma

AUGUST 22, 2024

In the rapidly evolving field of drug discovery, Melanie Adams-Cioaba stands at the forefront, leading transformative advancements in cryo-electron microscopy (cryo-EM) at Thermo Fisher Scientific.

121

121

pharmaphorum

AUGUST 16, 2024

On Wednesday, 14th August, the World Health Organization (WHO) announced the mpox outbreak in Africa as a public health emergency of international concern (PHEIC). By Thursday, 15th August, the first case of the severe variant was reported in Sweden, marking its emergence outside of Africa.

122

122

Fierce Healthcare

AUGUST 4, 2024

Medical records software giant Epic has rolled out a new feature that makes it easier for patients to release their medical records to the health or wellness apps they use. | The new capability is part of a wider effort by the healthcare industry, facilitated by new health tech policies from the federal government, to advance data-sharing at scale.

Medical Records 143

Medical Records 143

Pharmacy Times

AUGUST 26, 2024

Aligning with previous data, the drug combination was modestly effective in patients with large B-cell lymphoma pre- and post-CAR-T-cell therapy.

154

154

STAT

AUGUST 30, 2024

LONDON — Novo Nordisk made worldwide headlines last year when a study demonstrated that Wegovy, its powerful and exceedingly popular weight loss medicine, helped reduce the risk of cardiovascular emergencies like heart attacks.  Researchers on Friday unveiled results demonstrating another benefit that the drug offered to patients in that study: Compared to placebo, it cut the chances of dying from Covid-19 by roughly a third.

Immunization 139

Immunization 139

Fierce Pharma

AUGUST 5, 2024

The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago has filed another lawsuit against drugmakers that allegedly profited from | The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago has filed another lawsuit against drugmakers that allegedly profited from the discoveries they made using her genetic material.

145

145

STAT

AUGUST 27, 2024

In early 2022, I cared for one of the first patients with mpox in Massachusetts. As an infectious diseases physician, I remember the deep uncertainty I felt, and the fear in my patient’s eyes as a painful rash spread over their body. We were in uncharted territory — there were no proven treatments, and the number of cases was rapidly increasing.

Vaccines 142

Vaccines 142

STAT

AUGUST 26, 2024

Recently, Columbia University’s president resigned after months of chaos, following in the footsteps of Harvard and my own institution, Penn. Besides struggling with encampments, building takeovers, and commencement challenges, the three universities have something else in common: They have all chosen M.D.s as president or interim president.

144

144

STAT

AUGUST 27, 2024

Health insurer Centene will not pay any commissions to brokers and agents who help people sign up for next year’s Medicare prescription drug plans. “We have made a difficult decision — effective Jan. 1, 2025 — to cease new and renewal commissions for [Medicare Part D plans] beginning with the 2025 plan year,” Centene’s WellCare subsidiary said last Friday in an email sent to brokers, which was obtained by STAT.

Insurance 139

Insurance 139

STAT

AUGUST 27, 2024

In 2021, Katey Frederking had reached the end of her rope. The 29-year-old was struggling with frequent migraines, which started after a concussion from a fall on an icy patch near her home in Chicago. The medications she had been prescribed weren’t working, her doctor wasn’t listening, and she was facing several months of wait time before she could see a new neurologist.

142

142

STAT

AUGUST 27, 2024

Eli Lilly said Tuesday that it will start providing low-dose vials of its obesity drug Zepbound through its direct-to-consumer platform, a move that will likely ease supply constraints and draw more patients to the company’s online portal. Lilly is also selling the vials at a discount to the currently available injectable pens, which carry a list price of $1,060 for a month’s supply.

Dosage 141

Dosage Insurance 141

STAT

AUGUST 24, 2024

Anthony Fauci, former head of the National Institute of Allergy and Infectious Diseases, is recovering at home after being hospitalized for nearly a week for West Nile virus infection. Fauci, a leader of the U.S. Covid-19 response, spent six days in hospital as doctors tried to figure out what was responsible for his illness. It was thought he had a bacterial infection, or had been infected with a tick-borne disease, until a blood test showed he was “strongly positive” for West Nil

Hospitals 145

Hospitals Vaccines 145

STAT

AUGUST 24, 2024

News that Anthony Fauci, long-time former head of the National Institute of Allergy and Infectious Diseases, is recovering from a bad bout of West Nile virus fever throws a spotlight on a disease that sickens plenty of Americans every summer, but which gets little attention. Transmitted by mosquitoes, the virus causes symptom-free infections in most people who contract it.

Hospitals 145

Hospitals 145

STAT

AUGUST 26, 2024

NEW YORK — Glucose tracking is the future, Dexcom executives gushed at a glitzy launch event for their new, over-the-counter continuous glucose monitor on Wednesday evening. Surrounded by champagne, new celebrity ambassador and “Parks and Rec” actress Retta, and a mini-pickleball court, CEO Kevin Sayer declared victory.   “Dexcom has literally created an industry, and now it’s time to create a much broader revolution in health care,” Sayer told

142

142

STAT

AUGUST 23, 2024

I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent most disease and a lot of what we do in medicine doesn’t add value and sometimes even causes harm. So instead, I practice a seemingly radical but necessary idea for getting the best from medicine while avoiding excesses.

144

144

STAT

AUGUST 22, 2024

WASHINGTON — U.S. regulators approved  updated Covid-19 vaccines  on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter, too. With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses. A third U.S. manufacturer, Novavax, expects its updated vaccine version to be available a little later.

Vaccines 144

Vaccines FDA 144

STAT

AUGUST 21, 2024

For years, Black Americans have been more likely to die of cancer than white Americans. There is a widespread belief that cancer screening — tests to detect hidden cancer — can reduce this Black-white disparity. While it is important to be attentive to racial disparities in health and health care, the belief in screening is misguided. More cancer screening primarily serves the interests of the health care system, not those of Black Americans.

142

142

STAT

AUGUST 20, 2024

Last week, a mask ban in Nassau County, New York was signed into law. If I lived just 60 miles east of my New Jersey town, I would be under threat of a fine or jail time every time I left the house. I’ve been masking consistently in public since 2020, when the Covid-19 pandemic began, because I have a kidney transplant and will take immunosuppressant medication for the rest of my life.

Vaccines 145

Vaccines Hospitals 145

STAT

AUGUST 20, 2024

Eli Lilly’s obesity drug Zepbound significantly cut the risk of developing type 2 diabetes, showing the benefits of long-term use of the blockbuster therapy. In a Phase 3 trial that lasted over three years, people with pre-diabetes taking Zepbound had a 93% lower risk of progressing to diabetes compared with people on placebo, Lilly said Tuesday.

144

144